Display Settings:

Format

Send to:

Choose Destination
Lab Anim Res. 2014 Mar;30(1):35-43. doi: 10.5625/lar.2014.30.1.35. Epub 2014 Mar 24.

Metabolomics approach to serum biomarker for loperamide-induced constipation in SD rats.

Author information

  • 1Department of Biomaterials Science, College of Natural Resources & Life Science, Pusan National University, Miryang, Korea.
  • 2College of Pharmacy, Dankook University, Cheonan, Korea.
  • 3College of Pharmacy, Dankook University, Cheonan, Korea. ; Department of Medical Laser, Graduate School, Dankook University, Cheonan, Korea.
  • 4Department of Chemistry and Chemistry Institute for Functional Materials, Pusan National University, Busan, Korea.

Abstract

Loperamide has long been known as an opioid-receptor agonist useful as a drug for treatment of diarrhea resulting from gastroenteritis or inflammatory bowel disease as well as to induce constipation. To determine and characterize putative biomarkers that can predict constipation induced by loperamide treatment, alteration of endogenous metabolites was measured in the serum of Sprague Dawley (SD) rats treated with loperamide for 3 days using (1)H nuclear magnetic resonance ((1)H NMR) spectral data. The amounts and weights of stool and urine excretion were significantly lower in the loperamide-treated group than the No-treated group, while the thickness of the villus, crypt layer, and muscle layer was decreased in the transverse colon of the same group. The concentrations of aspartate aminotransferase (AST), lactate dehydrogenase (LDH) and creatinine (Cr) were also slightly changed in the loperamide-treated group, although most of the serum components were maintained at a constant level. Furthermore, pattern recognition of endogenous metabolites showed completely separate clustering of the serum analysis parameters between the No-treated group and loperamide-treated group. Among 35 endogenous metabolites, four amino acids (alanine, glutamate, glutamine and glycine) and six endogenous metabolites (acetate, glucose, glycerol, lactate, succinate and taurine) were dramatically decreased in loperamide-treated SD rats. These results provide the first data pertaining to metabolic changes in SD rats with loperamide-induced constipation. Additionally, these findings correlate the changes in 10 metabolites with constipation.

KEYWORDS:

constipation; loperamide; metabolomics; serum; transverse colon

PMID:
24707303
[PubMed]
PMCID:
PMC3973809
Free PMC Article

Images from this publication.See all images (5)Free text

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Korean Association for Laboratory Animal Science Icon for PubMed Central
    Loading ...
    Write to the Help Desk